HomeCompanyTechnologyProduct DevelopmentClinical StudiesNewsPartnering

News

Crescent Diagnostics and DeltaNu Ink IP Agreement

July 18th - Limerick, Ireland and Laramie, Wyoming USA: Crescent Diagnostics Ltd. has signed an intellectual property option agreement with DeltaNu LLC. This agreement gives Crescent an exclusive option to develop and market products from intellectual property that was invented at the University of Limerick and the University of Wyoming and is jointly held by Crescent and DeltaNu. The intellectual property describes a novel way to use Raman spectroscopy to diagnose bone health conditions like osteoporosis. The terms of the agreement were not disclosed.

"We are very happy to conclude an agreement like this - it formalizes a great working relationship we've had with DeltaNu for the past two years," says Ernest Poku, CEO of Crescent Diagnostics.

"The applications for Raman spectroscopy are growing," says Dr. Keith Carron, CEO of DeltaNu, "and DeltaNu is fortunate to partner with a leader like Crescent as it brings this important technology to the market."

About Crescent Diagnostics Ltd

Crescent Diagnostics Ltd was established in 2004 to develop and commercialize a bone quality test based on Raman technology. Crescent Diagnostics conducts research at its offices in Limerick, Ireland and maintains a corporate office in London, UK. The company is runby an experience medical diagnostics management team. For more information about Crescent Diagnostics, please visit the website at www.crescentds.com.

About DeltaNu LLC

As the pioneer and global leader in small footprint and handheld Raman spectrometers. DeltaNu has an insight for developing unique, low cost and high performance spectrometers for academics, industry, and OEM applications.

The mission of the company is to expand and offer affordable raman spectrometers to various markets. Founded in 1997, and launced out of the University of Wyoming, DeltaNu has been awarded over 4.5 million in research contracts. For more information about DeltaNu, please visit the website at www.deltanu.com.

Media Contact:
Ernest Poku, CEO
Crescent Diagnostics Ltd.
Tel: + 44 20 3006 3107
E-mail: ernie@crescentds.com

 

Website by Prickly Pear Design © 2005 - 2008